Visualization of Myelin for the Diagnosis and Treatment Monitoring of Multiple Sclerosis

Research output: Contribution to journalArticle

Abstract

Multiple sclerosis (MS) is a demyelinating disease of the central nervous system (CNS) affecting more than two million people worldwide. As the exact etiology of MS remains elusive, the diagnosis of MS is made by referring to the McDonald diagnostic criteria, which utilizes MRI as a tool to identify "demyelinated" MS lesions. In particular, hyperintense lesions on T2-weighted images (T2WI) or so-called "T2-lesions" are considered to represent demyelinated MS lesions. T2WI, however, lacks myelin specificity, and moreover, remyelination could not be depicted by the use of such modality. For the accurate diagnosis and treatment decision-making, or for the future development of remyelination therapeutics, imaging tools to visualize myelin-specific signals are mandatory. In this chapter, the current use and the limitation of imaging modalities in MS diagnosis and treatment will be reviewed, with the introduction of new imaging method, namely q-space Myelin Map (qMM), to be used for visualization of demyelination and remyelination in MS.

Original languageEnglish
Pages (from-to)249-256
Number of pages8
JournalAdvances in experimental medicine and biology
Volume1190
DOIs
Publication statusPublished - 2019 Jan 1

Keywords

  • Demyelination
  • MRI
  • Multiple sclerosis
  • q-space Myelin Map
  • Remyelination

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Fingerprint Dive into the research topics of 'Visualization of Myelin for the Diagnosis and Treatment Monitoring of Multiple Sclerosis'. Together they form a unique fingerprint.

  • Cite this